Nrf2 activation: a potential strategy for the prevention of acute mountain sickness. - Test2 - elhamkhani - TriplyDB

Nrf2 activation: a potential strategy for the prevention of acute mountain sickness.

Nrf2 activation: a potential strategy for the prevention of acute mountain sickness.

http://www.wikidata.org/entity/Q34347662

about

Oxidative Stress and Therapeutic Development in Lung Diseases The clinical potential of influencing Nrf2 signaling in degenerative and immunological disorders Genetic variants associated with motion sickness point to roles for inner ear development, neurological processes and glucose homeostasis.Discontinued in 2013: diabetic drugs.Nrf2 regulates PU.1 expression and activity in the alveolar macrophage.Topical application of RTA 408 lotion activates Nrf2 in human skin and is well-tolerated by healthy human volunteers Tim-3 inhibits macrophage control of Listeria monocytogenes by inhibiting Nrf2.Exploratory proteomic analysis of hypobaric hypoxia and acute mountain sickness in humans.Glutathione protects brain endothelial cells from hydrogen peroxide-induced oxidative stress by increasing nrf2 expression.Safety of carbonic anhydrase inhibitors.New insights into carbonic anhydrase inhibition, vasodilation, and treatment of hypertensive-related diseases.In search for better pharmacological prophylaxis for acute mountain sickness: looking in other directions.Pharmacology of acute mountain sickness: old drugs and newer thinking.Elucidating the Role of Protandim and 6-Gingerol in Protection Against Osteoarthritis.Ameliorative Effect of a Selective Endothelin ETA Receptor Antagonist in Rat Model of L-Methionine-induced Vascular Dementia.Acclimatization of the systemic microcirculation to alveolar hypoxia is mediated by an iNOS-dependent increase in nitric oxide availability.Mechanistic Role of Reactive Oxygen Species and Therapeutic Potential of Antioxidants in Denervation- or Fasting-Induced Skeletal Muscle Atrophy.An improved formula for standard hypoxia tolerance time (STT) to evaluate hypoxic tolerance in mice Antioxidative 1,4-Dihydropyridine Derivatives Modulate Oxidative Stress and Growth of Human Osteoblast-Like Cells In Vitro

P2860

Q28390572-86E4F1FB-74C2-48A9-8E36-DACCCFA6404D Q28395641-0614FB70-2016-44EF-A8F3-B58A5F8B9BFD Q30635212-39091380-2975-476C-8B64-5AE4F3F5AB7D Q34664870-F48C2984-DCB9-4E41-9169-DC6C9CADDE98 Q35622509-1EF19431-CEE4-4F3A-917E-075C070118E8 Q35690117-12608A68-7D91-4D9E-AB34-E322B25FBC4F Q37644227-272CCC43-5A0C-4607-99F2-D5C05E0DEEE2 Q37679368-BA0E5483-1524-4B58-8BDC-92349E3F9090 Q37700147-611EC416-31E6-45C0-A39F-A36755B422C5 Q38194570-A5D08E06-D0D1-4938-84DD-93AD20A348DD Q38235629-71F6E6C6-A241-4579-8963-6713970446CF Q38380577-22B05B57-0D23-443B-B877-443D82A38566 Q38570831-09960AA0-E563-49BC-8994-C6B5D517B0BF Q39555020-E2AA1C7B-FB9F-4972-9F7C-D4D132BDAF41 Q41197143-E4573D35-8A11-4BF0-9E92-922A8CA9DCA7 Q46403028-4439ADBD-BA8A-4EE6-A1A0-DB1FAF092BB7 Q51244058-DE43CADA-E078-4CD9-8E3B-C29F5A23F9DF Q57091298-B757B8D5-70E7-448D-9A8A-3CE09DF358B7 Q58716697-49893D2E-B256-476F-8809-7A85C5A5D5A5

P2860

Nrf2 activation: a potential strategy for the prevention of acute mountain sickness.

http://www.wikidata.org/entity/Q34347662

description

2013 nî lūn-bûn

@nan

2013 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Nrf2 activation: a potential strategy for the prevention of acute mountain sickness.

@ast

Nrf2 activation: a potential strategy for the prevention of acute mountain sickness.

@en

Nrf2 activation: a potential strategy for the prevention of acute mountain sickness.

@nl

type

label

Nrf2 activation: a potential strategy for the prevention of acute mountain sickness.

@ast

Nrf2 activation: a potential strategy for the prevention of acute mountain sickness.

@en

Nrf2 activation: a potential strategy for the prevention of acute mountain sickness.

@nl

prefLabel

Nrf2 activation: a potential strategy for the prevention of acute mountain sickness.

@ast

Nrf2 activation: a potential strategy for the prevention of acute mountain sickness.

@en

Nrf2 activation: a potential strategy for the prevention of acute mountain sickness.

@nl

P1433

Q34347662-E28146D6-1291-4544-84B7-A895811B4D19

P1476

Q34347662-9E6619BB-83EA-4352-902A-71BFDF234D73

P2093

Q34347662-36CE2D45-79E0-4629-9343-C8DD231BD2B0

Q34347662-4A1A2235-A589-4EDE-8E71-40B2F0C7975B

Q34347662-4E71A0E7-CE8E-40C7-88A3-20018E2A5545

Q34347662-5301481B-92A6-4CFA-B090-D6267F10F4C4

Q34347662-61A4A9A8-611E-4263-9721-617041D36555

Q34347662-7DCD72D8-E5D0-4E86-999A-FEF6AD6DE304

Q34347662-840D3849-F7DA-4DA2-8CD7-C445C60F6094

Q34347662-857D4224-0CAB-4B89-BC0C-76818C600352

Q34347662-99DEDC8C-36C1-4106-A8F5-BD8F51836D3F

P2860

Q34347662-03AC3925-D89D-4DF5-8CCD-5680F2C567B2

Q34347662-05862C5E-F187-4625-B5D6-CAA6A4AC2598

Q34347662-06BA015D-F87D-4936-8470-158A311C9BE5

Q34347662-1797DFE9-64DE-4BA5-8DF1-990881CBA631

Q34347662-1B57FAFA-6BF7-4CC2-AF08-E0E1B8F434BD

Q34347662-1E980F9A-1A38-45B3-A6A1-602F0A75468A

Q34347662-2CC581D9-A37A-4753-993A-8C41C7E9DFBB

Q34347662-3B221C3D-4BFF-465E-8B58-1870A52C8199

Q34347662-42EA16A1-4415-4268-BA53-9A28F3E766B8

Q34347662-4320CF47-D3B6-44A2-898A-193D7DC2B9A3

P304

Q34347662-BFEC2BBF-D7C6-467E-8EAD-A38A31CA7CB3

P31

Q34347662-BDC43799-1C56-4527-B0FE-962D0DED06FD

P356

Q34347662-7D670E56-3F98-47B2-8BE9-C25D509F717B

P478

Q34347662-A7F1A0F2-96A8-42B1-BC18-5FE812018FBA

P577

Q34347662-60C542D8-EAD2-4DBF-9B8D-5D7EAF630B4A

P5875

Q34347662-F08442FC-92B5-46BC-A4E3-D8913ECE2F0F

P698

Q34347662-3064DDFE-C947-4C16-A074-E4BF195DE2BA

P932

Q34347662-5B4E0488-786B-422D-B939-C21EF5D36530

P356

J.FREERADBIOMED.2013.05.024

P1433

Free Radical Biology and Medicine

P1476

Nrf2 activation: a potential strategy for the prevention of acute mountain sickness.

@en

P2093

Christina Lisk

http://www.w3.org/2001/XMLSchema#string

David C Irwin

http://www.w3.org/2001/XMLSchema#string

Eva Nozik-Grayck

http://www.w3.org/2001/XMLSchema#string

Joe McCord

http://www.w3.org/2001/XMLSchema#string

Karyn Hamilton

http://www.w3.org/2001/XMLSchema#string

Swapan Bose

http://www.w3.org/2001/XMLSchema#string

Thies Schroeder

http://www.w3.org/2001/XMLSchema#string

Tim Sullivan

http://www.w3.org/2001/XMLSchema#string

Zoe Loomis

http://www.w3.org/2001/XMLSchema#string

P2860

Protandim, a fundamentally new antioxidant approach in chemoprevention using mouse two-stage skin carcinogenesis as a model

The chemopreventive effects of Protandim: modulation of p53 mitochondrial translocation and apoptosis during skin carcinogenesis

The Dietary Supplement Protandim® Decreases Plasma Osteopontin and Improves Markers of Oxidative Stress in Muscular Dystrophy Mdx Mice

Acute mountain sickness: pathophysiology, prevention, and treatment

Dose translation from animal to human studies revisited

Emerging concepts in acute mountain sickness and high-altitude cerebral edema: from the molecular to the morphological

Altitude illness: update on prevention and treatment.

Protandim attenuates intimal hyperplasia in human saphenous veins cultured ex vivo via a catalase-dependent pathway.

Oxidative stress in health and disease: the therapeutic potential of Nrf2 activation.

Pharmacologic prophylaxis for acute mountain sickness: a systematic shortcut review.

P304

264-273

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.FREERADBIOMED.2013.05.024

http://www.w3.org/2001/XMLSchema#string

P478

63

http://www.w3.org/2001/XMLSchema#string

P577

2013-05-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236976752

http://www.w3.org/2001/XMLSchema#string

P698

23722164

http://www.w3.org/2001/XMLSchema#string

P932

4130652

http://www.w3.org/2001/XMLSchema#string